Lonza News 11. Mai 2026 Lonza says big pharma might delay outsourcing decisions amid US investments - MSN
Merck & Co. 11. Mai 2026 Merck makes a new move in Astra battle | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Merck & Co. 11. Mai 2026 Amid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase data - Fierce Biotech
PLoS Biology 11. Mai 2026 The problem with one-size-fits-all medicine: Biological sex and the aging immune system
PLoS Biology 11. Mai 2026 USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STING
BioPharma Dive 11. Mai 2026 Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
Charles River 11. Mai 2026 Charles River Laboratories Introduces AI-Powered, End-to-End Workflow - Contract Pharma
Endpoints News 11. Mai 2026 Braveheart Bio's Hengrui-licensed cardiac drug scores second clinical win
FierceBiotech 11. Mai 2026 Novo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotech
GE HealthCare 11. Mai 2026 GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact - Business Wire